MedX Health Corp (TSXV:MDX)
Canada · Delayed Price · Currency is CAD 0.0500
0.00 (0.00%)
Aug 21, 2026, 12:11 PM EST
MedX Health Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.04 | 0.02 | 0.16 | 0.14 | 0.14 | 0.11 |
Cash & Short-Term Investments | 0.04 | 0.02 | 0.16 | 0.14 | 0.14 | 0.11 |
Cash Growth | 220.55% | -88.16% | 14.55% | -3.02% | 33.46% | 181.36% |
Accounts Receivable | 0.08 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 |
Other Receivables | 0.02 | 0.11 | 0.26 | 0.11 | 0.04 | - |
Receivables | 0.1 | 0.13 | 0.29 | 0.11 | 0.05 | 0.01 |
Inventory | 0.15 | 0.19 | 0.38 | 0.34 | 0.38 | 0.37 |
Prepaid Expenses | 0.04 | 0.08 | 0.02 | 0.02 | 0.02 | 0.05 |
Total Current Assets | 0.32 | 0.41 | 0.84 | 0.6 | 0.58 | 0.54 |
Property, Plant & Equipment | 0.28 | 0.29 | 0.04 | 0.09 | 0.14 | 0.19 |
Total Assets | 0.6 | 0.7 | 0.88 | 0.69 | 0.72 | 0.73 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.26 | 0.55 | 0.34 | 0.63 | 0.62 | 0.5 |
Accrued Expenses | 2.31 | 1.89 | 1.9 | 1.34 | 1.54 | 0.66 |
Short-Term Debt | 4.44 | 6.28 | 3.95 | 0.66 | 1.06 | 0.15 |
Current Portion of Long-Term Debt | 1.46 | 1.4 | 1.95 | 4.25 | 3.02 | - |
Current Portion of Leases | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 | 0.04 |
Current Income Taxes Payable | - | - | - | - | 0.64 | 0.6 |
Current Unearned Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Other Current Liabilities | 0.04 | 0.01 | 0.14 | 0.01 | - | - |
Total Current Liabilities | 8.56 | 10.19 | 8.33 | 6.95 | 6.92 | 1.97 |
Long-Term Debt | 1.24 | 0.01 | 1.08 | 0.84 | 0.79 | 2.26 |
Long-Term Leases | 0.23 | 0.24 | - | 0.04 | 0.09 | 0.13 |
Total Liabilities | 10.03 | 10.44 | 9.41 | 7.83 | 7.8 | 4.36 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 30.73 | 30.73 | 27.49 | 26.95 | 23.96 | 23.94 |
Additional Paid-In Capital | 16.61 | 16.59 | 14.36 | 11.61 | 10.85 | 9.88 |
Retained Earnings | -62.02 | -60.79 | -54.5 | -50.85 | -46.27 | -41.14 |
Comprehensive Income & Other | 5.25 | 3.73 | 4.13 | 5.15 | 4.38 | 3.69 |
Shareholders' Equity | -9.43 | -9.74 | -8.52 | -7.14 | -7.08 | -3.63 |
Total Liabilities & Equity | 0.6 | 0.7 | 0.88 | 0.69 | 0.72 | 0.73 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 7.42 | 7.97 | 7.01 | 5.84 | 5 | 2.58 |
Net Cash (Debt) | -7.38 | -7.96 | -6.86 | -5.71 | -4.86 | -2.47 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 | -0.01 |
Filing Date Shares Outstanding | 327.93 | 327.93 | 285.81 | 261.96 | 183.8 | 183.7 |
Total Common Shares Outstanding | 327.93 | 327.93 | 272.31 | 261.96 | 183.8 | 183.7 |
Working Capital | -8.23 | -9.78 | -7.49 | -6.35 | -6.34 | -1.43 |
Book Value Per Share | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 | -0.02 |
Tangible Book Value | -9.43 | -9.74 | -8.52 | -7.14 | -7.08 | -3.63 |
Tangible Book Value Per Share | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 | -0.02 |
Machinery | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 |